Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI and Boston Children’s Hospital enter evaluation agreement
PHI and Boston Children’s Hospital – a Harvard Medical School teaching hospital – have signed an agreement to evaluate PHI’s HoloMonitor®technology for applications in cell-based cancer research.
Learn more …
PostPress Release
PHI and Boston Children’s Hospital enter evaluation agreement
Learn more …
PostPress Release
Big Pharma company orders third HoloMonitor
Learn more …
PostPress Release
HoloMonitor provide vital information to development of improved child cancer treatment
Learn more …
PostNews: Press Release
PHI achieves market acceptance goals
Prior to the company’s IPO in early 2014, three market acceptance goals were set out to be achieved by the end of 2015: 50 units in operation at customers and key opinion leaders, collaboration agreements with 8 key opinion leaders and the company’s main product HoloMonitor® M4 shall be manufactured in series production.
Learn more …
PostPress Release
PHI invited to speak at world leading scientific event
Learn more …